Articles with public access mandates - Richard MessmannLearn more
Available somewhere: 8
Lutetium-177–PSMA-617 for metastatic castration-resistant prostate cancer
O Sartor, J De Bono, KN Chi, K Fizazi, K Herrmann, K Rahbar, ST Tagawa, ...
New England Journal of Medicine 385 (12), 1091-1103, 2021
Mandates: US National Institutes of Health
Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
F Shah, D Logsdon, RA Messmann, JC Fehrenbacher, ML Fishel, ...
NPJ precision oncology 1 (1), 19, 2017
Mandates: US National Institutes of Health
The multifunctional APE1 DNA repair–redox signaling protein as a drug target in human disease
RA Caston, S Gampala, L Armstrong, RA Messmann, ML Fishel, ...
Drug Discovery Today 26 (1), 218-228, 2021
Mandates: US Department of Defense, US National Institutes of Health
Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan™
EL Matteson, VJ Lowe, FG Prendergast, CS Crowson, KG Moder, ...
Clinical and experimental rheumatology 27 (2), 253, 2009
Mandates: US National Institutes of Health
Clinical Pharmacokinetics and Exposure‐Toxicity Relationship of a Folate‐Vinca Alkaloid Conjugate EC145 in Cancer Patients
J Li, EA Sausville, PJ Klein, D Morgenstern, CP Leamon, RA Messmann, ...
The Journal of Clinical Pharmacology 49 (12), 1467-1476, 2009
Mandates: US National Institutes of Health
Health-related quality of life and pain outcomes with [177Lu] Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant …
K Fizazi, K Herrmann, BJ Krause, K Rahbar, KN Chi, MJ Morris, O Sartor, ...
The Lancet Oncology 24 (6), 597-610, 2023
Mandates: US National Institutes of Health, UK Medical Research Council
Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide
WV Rodrigueza, MJ Woolliscroft, AS Ebrahim, R Forgey, PJ McGovren, ...
Cancer chemotherapy and pharmacology 74, 151-166, 2014
Mandates: US National Institutes of Health
Bridging population pharmacokinetic and semimechanistic absorption modeling of APX3330
LL Silva, RE Stratford, R Messmann, MR Kelley, SK Quinney
CPT: Pharmacometrics & Systems Pharmacology 13 (1), 106-117, 2024
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program